IP Library Granted Patent US 7,955,632
Granted Patent B2
US 7,955,632 · App. 11/940,106 · Granted Jun 7, 2011

Process for manufacturing chewable dosage forms for drug delivery and products thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,955,632
App. No.
11/940,106
Granted
Jun 7, 2011
Kind
B2
Abstract

A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.

Claims (20)

1. A process for manufacturing, without use of extrusion, an edible, soft chewable medication vehicle (a “soft chew”) having consistent unit-to-unit weight and active content, wherein the soft chew is palatable to dogs and cats, comprising:

(a) providing an active agent and an oil, wherein the active agent is an antibiotic whose stability or potency can be adversely affected by temperatures typically generated during extrusion, an active agent that is not palatable, or both;

(b) blending the active agent of step (a) with dry inactive ingredients including at least one each of a flavoring, a binder, a bulking agent, a humectant and an excipient, wherein all such dry inactive ingredients are free of infectious agents or contaminants, and the oil, all of the blending being performed in a low shear mixer, wherein operation of the mixer causes a dry edible soft chew mixture to be formed having the active agent uniformly blended therein;

(c) adding a water-soluble polyethylene glycol anti-sticking agent to the dry mixture and blending it therein using the low shear mixer to form a edible soft chewable mixture;

(d) removing the edible soft chewable mixture from the mixer; and,

(e) molding the edible soft chewable mixture into individual unit masses without application of compression heat thereto, wherein the unit masses so formed are of consistent weight and active content from unit to unit and are generally more palatable to cats and dogs than tablet dosage forms of the active agent,

wherein the edible soft chew mixture and the ingredients thereof are maintained at room temperature or no more than +/−10° C. thereof during performance of each step of the method, and wherein further no water is added to the active agent during performance of the method.

2. The method according to claim 1 , wherein the active is an antibiotic whose potency or stability is adversely affected at temperatures 10° C. over or under room temperature.

3. The process according to claim 1 , wherein the flavoring is a soy protein product.

4. The process according to claim 1 , wherein the dry inactive ingredients are all of non-animal origin.

5. The process according to claim 1 , wherein the humectant is glycerin or cetyl alcohol.

6. The process according to claim 1 , wherein the inactive ingredients further comprise a preservative.

7. The process according to claim 1 , wherein the excipient is at least one of crospovidone, croscarmellose sodium, cellulose, starch, pregelatinized starch, and sodium starch glycolate.

8. The process according to claim 1 , wherein the inactive ingredients further comprise a softening agent.

9. The process according to claim 8 , wherein the softening agent comprises magnesium stearate.

10. The process according to claim 5 , wherein the humectant is glycerin.

11. The process according to claim 7 , wherein the excipient comprises pregelatinized starch that has been chemically and/or mechanically modified to rupture all or part of the starch granules.

12. The process according to claim 11 , wherein the excipient further comprises croscarmellose sodium.

13. The process according to claim 1 , wherein the oil is a vegetable oil.

14. The process according to claim 1 , wherein the bulking agent is bran, meal, flour, cereal, fiber, whole grains, vegetables, seeds, gum arabic, pectins, modified starches, alginates, carrageenans, xanthan gums, carboxymethylcellulose, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, propylene glycol alginate, polyvinylpyrrolidone, carboxyvinyl polymers, polyethylene oxide polymers, talc, dicalcium phosphate and antacids.

Assignments (4)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON OCTOBER 29, 2020, AT REEL/FRAME 054217/0148 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0043 →
SECURITY INTEREST Recorded Oct 29, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 054217/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: BAYER HEALTHCARE LLC
To: ELANCO US INC.
Reel/Frame 054023/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2013
From: BAYER B.V.
To: BAYER HEALTHCARE, LLC
Reel/Frame 031561/0077 →